We are live on ! Find out more
Rafferty Asset Management

Rafferty Asset Management Portfolio holdings

AUM $24.6B
1-Year Est. Return 47.06%
This Fund
S&P 500
This Quarter Est. Return
+10.61%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$6.5B
AUM Growth
+$106M
Cap. Flow
-$484M
Cap. Flow %
-7.44%
Top 10 Hldgs %
52.66%
Holding
925
New
127
Increased
448
Reduced
289
Closed
61

Sector Composition

Rank Sector Weight
1 Financials 12.12%
2 Technology 8.06%
3 Healthcare 5.67%
4 Energy 5.37%
5 Real Estate 3.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HBAN icon
226
Huntington Bancshares
HBAN
$34B
$2.92M 0.04%
193,475
+12,397
+7% +$182K
PE
227
DELISTED
PARSLEY ENERGY INC
PE
$2.92M 0.04%
154,317
-32,516
-17% -$537K
BKNG icon
228
Booking.com
BKNG
$156B
$2.89M 0.04%
35,175
+4,525
+15% +$355K
BKR icon
229
Baker Hughes
BKR
$58.3B
$2.89M 0.04%
112,616
-39,510
-26% -$898K
MAA icon
230
Mid-America Apartment Communities
MAA
$16B
$2.88M 0.04%
21,845
+1,774
+9% +$237K
AJG icon
231
Arthur J. Gallagher & Co
AJG
$69.1B
$2.87M 0.04%
30,156
+2,381
+9% +$218K
PTCT icon
232
PTC Therapeutics
PTCT
$6.18B
$2.87M 0.04%
59,653
-29,771
-33% -$1.27M
IOVA icon
233
Iovance Biotherapeutics
IOVA
$2.04B
$2.85M 0.04%
102,990
-138,670
-57% -$3.15M
PHM icon
234
Pultegroup
PHM
$25.2B
$2.85M 0.04%
73,384
+6,381
+10% +$248K
AGIO icon
235
Agios Pharmaceuticals
AGIO
$2.08B
$2.84M 0.04%
59,455
-56,518
-49% -$2.14M
EXC icon
236
Exelon
EXC
$48.1B
$2.84M 0.04%
87,251
+68,586
+367% +$2.22M
MAC icon
237
Macerich
MAC
$7.4B
$2.83M 0.04%
105,094
-2,828
-3% -$77.7K
CSCO icon
238
Cisco
CSCO
$443B
$2.8M 0.04%
58,430
+10,558
+22% +$491K
SLAB icon
239
Silicon Laboratories
SLAB
$7.14B
$2.8M 0.04%
24,128
+3,273
+16% +$359K
EFX icon
240
Equifax
EFX
$22B
$2.79M 0.04%
19,941
+1,646
+9% +$228K
PDCE
241
DELISTED
PDC Energy, Inc.
PDCE
$2.78M 0.04%
106,067
-14,498
-12% -$348K
WBA
242
DELISTED
Walgreens Boots Alliance
WBA
$2.77M 0.04%
46,941
+2,962
+7% +$171K
WOLF icon
243
Wolfspeed
WOLF
$1.04B
$2.77M 0.04%
59,919
+8,447
+16% +$394K
EBAY icon
244
eBay
EBAY
$51.2B
$2.75M 0.04%
76,195
+8,447
+12% +$306K
ROST icon
245
Ross Stores
ROST
$80.8B
$2.73M 0.04%
23,490
+972
+4% +$109K
KO icon
246
Coca-Cola
KO
$383B
$2.73M 0.04%
49,238
+3,874
+9% +$208K
XEL icon
247
Xcel Energy
XEL
$49.2B
$2.7M 0.04%
42,490
+2,432
+6% +$152K
ACGL icon
248
Arch Capital
ACGL
$36.5B
$2.7M 0.04%
62,868
-22,413
-26% -$930K
SBUX icon
249
Starbucks
SBUX
$119B
$2.69M 0.04%
30,643
+3,916
+15% +$334K
CMCSA icon
250
Comcast
CMCSA
$87.3B
$2.69M 0.04%
59,862
+6,334
+12% +$282K

Similar funds

Rafferty Asset Management's Q4 2019 Portfolio in Review

As of Q4 2019, Rafferty Asset Management held 925 positions worth $6.5B, up 1.7% from $6.39B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Rafferty Asset Management withdrew a net $484M in Q4 2019, closing 61 positions and reducing 289 holdings. Its most notable exit was State Street Health Care Select Sector SPDR ETF, an estimated $83.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 11% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Rafferty Asset Management opened a new position in Moderna worth $3.18M.

  • Rafferty Asset Management's largest Q4 2019 buy was Moderna: 162,744 shares worth $3.18M.
  • Rafferty Asset Management added most to iShares Core S&P 500 ETF in Q4 2019, an estimated $56.2M increase.
  • Rafferty Asset Management's biggest Q4 2019 reduction was iShares Russell 2000 ETF, cutting an estimated $94.9M.
  • Rafferty Asset Management fully exited State Street Health Care Select Sector SPDR ETF in Q4 2019, selling an estimated $83.7M.
  • Rafferty Asset Management's ten largest holdings make up 53% of its $6.5B portfolio in Q4 2019.
  • Rafferty Asset Management opened 127 new positions and closed 61 in Q4 2019.
  • Rafferty Asset Management's portfolio value rose 1.7% quarter-over-quarter to $6.5B.

Based on Rafferty Asset Management's 13F filing for Q4 2019, filed 10 Feb 2020.